Top Sell
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €5.40 | - | - |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.39 | - | - |
| Coherus Bioscien. | 1 | 2 | 0 | 0 | €1.49 | - | - |
| Vaxart Inc. | 0 | 1 | 0 | 0 | €0.63 | - | - |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €8.55 | €110.00 | 1186.550% |
| Orasure Tech | 3 | 1 | 0 | 0 | €3.98 | €8.36 | 110.008% |
| Arca Biopharma | 0 | 17 | 0 | 1 | €2.90 | - | - |
| Gritstone Oncology Inc | 4 | 2 | 0 | 0 | €0.64 | €5.07 | 696.619% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.37 | €3.00 | 716.549% |
| QuidelOrtho Corp. | 7 | 2 | 0 | 0 | €34.20 | €75.48 | 120.713% |
| Cyclacel Pharmaceuticals Inc. | 2 | 10 | 0 | 0 | €0.22 | €14.66 | 6565.591% |
| Mirati Therapeutics Inc. | 2 | 10 | 0 | 0 | €53.84 | €78.43 | 45.666% |
| Evoke Pharma Inc. | 0 | 25 | 0 | 2 | €0.44 | - | - |
| Glycomimetics Inc. | 5 | 3 | 0 | 1 | €0.21 | €7.35 | 3409.117% |
| Cara Therapeutics Inc. | 11 | 4 | 0 | 2 | €0.36 | €4.62 | 1199.494% |
| Bellicum Pharmaceuticals Inc. | 0 | 12 | 0 | 0 | €0.064 | - | - |
| Palatin Technologies Inc. | 0 | 4 | 0 | 0 | €1.65 | - | - |
| Ironwood Pharmaceuticals | 8 | 1 | 0 | 0 | €6.30 | €18.80 | 198.367% |
| Waters Corp. | 0 | 5 | 0 | 1 | €281.80 | €256.55 | -8.961% |
| Inotiv Inc. | 3 | 1 | 0 | 0 | €1.89 | €10.66 | 464.111% |
| Minerva Neurosciences Inc. | 0 | 9 | 0 | 3 | €2.92 | - | - |
| Organovo Holdings Inc. | 0 | 8 | 0 | 1 | €0.52 | - | - |
| Cardiff Oncology Inc. | 2 | 4 | 0 | 0 | €2.18 | €5.00 | 129.358% |
| NanoVibronix Inc. | 0 | 1 | 0 | 0 | €0.68 | - | - |
| Trevena Inc. | 2 | 19 | 0 | 1 | €0.18 | €6.48 | 3541.573% |